TCS, HDFCBANK, SBI Liquid Fund (G)
Biocon Ltd.
Biocon
NSE
₹ 0.00
0.00 (0.00)%
Healthcare
Mid-cap
With a market cap of ₹18.90L Cr.
Moderate Volatility
Stock is 1.13x as volatile as index
| EX-Date | Purpose |
|---|---|
| 28 04 2021 | Final Dividend & Audited Results |
| 22 07 2021 | Quarterly Results |
| 21 10 2021 | Quarterly Results |
| 20 01 2022 | Quarterly Results |
| 28 04 2022 | Audited Results & Dividend |
| 27 07 2022 | Quarterly Results |
| 14 11 2022 | Quarterly Results |
| 14 02 2023 | Quarterly Results |
| 26 04 2023 | Inter alia, to consider the issue of Secured, Redeemable, Non-Convertible Debentures on private placement basis, investment in securities to be issued by Biocon Biologics Limited and provision of guarantees/put options, amongst other matters. |
| 23 05 2023 | Final Dividend & Audited Results & A.G.M. |
| 10 08 2023 | Quarterly Results |
| 10 11 2023 | Quarterly Results |
| 08 02 2024 | Quarterly Results |
| 16 05 2024 | Audited Results & Final Dividend |
| 30 10 2024 | Quarterly Results |
| 27 01 2025 | Inter alia, to consider and approve:- (1) Raising of Funds through issuance of Commercial Papers (CPs) or through any other mode on private placement basis. |
| 30 01 2025 | Quarterly Results |
| 04 04 2025 | Inter alia, to consider and approve raising funds through issuance of Commercial Papers or through any other mode |
| 23 04 2025 | Inter alia, to consider and approve the proposal for raising of funds by way of issue of equity shares or any other eligible securities, through one or more of the permissible modes including but not limited to qualified institutions placement, rights issue, preferential issue, further public offer, etc. |
| 08 05 2025 | Final Dividend & Audited Results |
News
No News data available
